CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 30, 2020 · Phase 3 readout

NVO Phase 3 readout: a positive outcome, +6.1%

On March 30, 2020, Novo Nordisk A/S reached its Phase 3 readout. The result was a positive outcome, and the stock moved +6.1% in the window around the event.

The move

$28.36
1d before
$30.09
Event day
$30.10
1d after
$29.92
5d after

Pre-catalyst setup

-2.4%
30-day run-up
7195%
30-day volatility